AQR Capital Management »

Larimar Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $103k 16k 6.55
2024-06-30 $113k 16k 7.25

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Henderson Group
Goldman Sachs Group
Blue Owl Capital Holdings
BlackRock
Vanguard Group
Adage Capital Partners GP
Driehaus Capital Management
Woodline Partners
Verition Fund Management
State Street Corporation
Geode Capital Management
Altium Capital Management
Mangrove Partners

View all funds holding Larimar Therapeutics